Recently, Telmisartan, an angiotensin receptor blocker used in the management of hypertension or heart failure, was found to activate the AMPK-Sirt1 pathway in skeletal muscle, and ameliorate insulin sensitivity of obese db/db mice [30]. This evidence concerns the gene INS and hypertensive disorder.